Oncology and Hematology
Oncology and Hematology Clinical Practice
Stay current with Oncology and Hematology education that fits how you practice. ReachMD offers practical, on-demand clinical content for oncologists, hematologists, oncology nurses, pharmacists, fellows, APPs, and the full cancer care team. Explore expert discussions, case-based programs, CME/CE opportunities, industry features, and news across solid tumors, hematologic malignancies, biomarker-driven care, immunotherapy, targeted therapy, supportive care, and more.
Use this page to find relevant oncology and hematology content fast. Browse Project Oncology episodes, jump into CME/CE activities, review expert perspectives, or explore timely updates on evolving treatment strategies and standards of care. New content is added regularly, so you can stay current with emerging evidence, guideline updates, and multidisciplinary approaches to cancer care on your schedule.
Start with the latest programs below or browse by content type to find the Oncology and Hematology education most relevant to your practice.
91-105 of 355
The Future of HNSCC: Aligning Teams, Transforming Care
CME/CEThe Future of HNSCC: Aligning Teams, Transforming Care
Ravindra Uppaluri, MD, PhD
Nancy Lee, MD, FASTRO
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
CME/CEChairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
Benjamin Levy, MD
Advancing Bispecific Antibodies Upstream in the Treatment Paradigm of Multiple Myeloma
CME/CEAdvancing Bispecific Antibodies Upstream in the Treatment Paradigm of Multiple Myeloma
María-Victoria Mateos, MD, PhD
Targeting B7-H3 in ES-SCLC: Advancing Targeted Therapy Through Evidence-Based Innovation and Multidisciplinary Care
CME/CETargeting B7-H3 in ES-SCLC: Advancing Targeted Therapy Through Evidence-Based Innovation and Multidisciplinary Care
Taofeek K. Owonikoko, MD, PhD
Progress in Breast Cancer Care: Translating SABCS Data Into Practice
CME/CEProgress in Breast Cancer Care: Translating SABCS Data Into Practice
Charles E. Geyer Jr., MD, FACP
Komal Jhaveri, MD, FACP
Advancing Care in HNSCC: Evolving Strategies Across the Disease Continuum
CME/CEAdvancing Care in HNSCC: Evolving Strategies Across the Disease Continuum
Kevin J Harrington, PhD, FRCP, FRCR, FRSB
Cristina Rodriguez, MD
- advertisement
Double-Class Refractory CLL in Community Practice: Current and Future Management
CME/CEDouble-Class Refractory CLL in Community Practice: Current and Future Management
John C. Byrd, MD
William Mencia, MD, FACEHP
From Late-Line Rescue to Early-Line Option: The Potential for Bispecific Antibodies in Multiple Myeloma
CME/CEFrom Late-Line Rescue to Early-Line Option: The Potential for Bispecific Antibodies in Multiple Myeloma
María-Victoria Mateos, MD, PhD
Luciano Costa, MD, PhD
William Wierda, MD, PhD
Matthew S. Davids, MD, MMSc
Navigating Treatment Sequencing After Frontline Treatment Failure in CLL
CME/CENavigating Treatment Sequencing After Frontline Treatment Failure in CLL
Jennifer R. Brown, MD, PhD
William Mencia, MD, FACEHP
Novel RAS-Targeted Therapy: Prevention, Monitoring, and Mitigation of Adverse Events
MinuteCE®Novel RAS-Targeted Therapy: Prevention, Monitoring, and Mitigation of Adverse Events
Eileen M. O'Reilly, MD
Kathryn Arbour
- MinuteCE®
The New Era of RAS Targeting: Mechanisms, Evidence, and Clinical Integration of ON-State Inhibitors
Kathryn Arbour
Eileen M. O'Reilly, MD
- advertisement
NSCLC Data Review: Efficacy and Safety Data for ON-State RAS Inhibitors
MinuteCE®NSCLC Data Review: Efficacy and Safety Data for ON-State RAS Inhibitors
Kathryn Arbour
RAS(ON) and Beyond: Clinical Integration and Strategic Sequencing
MinuteCE®RAS(ON) and Beyond: Clinical Integration and Strategic Sequencing
Kathryn Arbour
Eileen M. O'Reilly, MD
Unmet Need: Second-Line Outcomes Remain Poor for NSCLC and Pancreatic Cancer
MinuteCE®Unmet Need: Second-Line Outcomes Remain Poor for NSCLC and Pancreatic Cancer
Kathryn Arbour
Eileen M. O'Reilly, MD
